Operating Lease, Right-of-Use Asset of NEUROONE MEDICAL TECHNOLOGIES Corp from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $226,251, a 33% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $226,251 -$113,020 -33% 31 Dec 2025 10-Q 17 Feb 2026 2026 Q1
Q3 2025 $255,195 +$285 +0.11% 30 Sep 2025 10-Q 17 Feb 2026 2026 Q1
Q2 2025 $283,621 +$1,788 +0.63% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q3
Q1 2025 $311,652 +$200,928 +181% 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 $339,271 +$199,073 +142% 31 Dec 2024 10-Q 12 Feb 2025 2025 Q1
Q3 2024 $254,910 +$85,851 +51% 30 Sep 2024 10-K 17 Dec 2025 2025 FY
Q2 2024 $281,833 +$84,509 +43% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 $110,724 -$114,281 -51% 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 $140,198 -$111,921 -44% 31 Dec 2023 10-Q 13 Feb 2024 2024 Q1
Q3 2023 $169,059 -$12,296 -6.8% 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 $197,324 -$11,604 -5.6% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 $225,005 -$11,038 -4.7% 31 Mar 2023 10-Q 12 May 2023 2023 Q2
Q4 2022 $252,119 -$10,594 -4% 31 Dec 2022 10-Q 13 Feb 2023 2023 Q1
Q3 2022 $181,355 -$107,593 -37% 30 Sep 2022 10-K 15 Dec 2023 2023 FY
Q2 2022 $208,928 -$32,228 -13% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 $236,043 -$19,366 -7.6% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $262,713 -$6,219 -2.3% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 $288,948 +$6,737 +2.4% 30 Sep 2021 10-K 22 Dec 2022 2022 FY
Q2 2021 $241,156 -$54,095 -18% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 $255,409 -$52,646 -17% 31 Mar 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 $268,932 -$56,316 -17% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 $282,211 30 Sep 2020 10-K/A 31 May 2022 2021 FY
Q2 2020 $295,251 30 Jun 2020 10-Q 13 Aug 2020 2020 Q3
Q1 2020 $308,055 31 Mar 2020 10-Q 14 May 2020 2020 Q2
Q4 2019 $325,248 31 Dec 2019 10-Q 14 Feb 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.